5 Questions With Matt Bumgardner, Vice President and Chief Operating Officer of R.W. Warner Inc. 

Published on : Published by : BioBuzz Media

Matt oversees all aspects of the three divisions of the company, Warner Construction, Kaempf and Harris Sheet Metal, and Warner Mechanical. He has been in construction for as long as he can remember, working for his step-father’s construction company whenever he could as a kid. Matt obtained a Mechanical Engineering degree from the University of Tennessee in Knoxville and traveled the world with the Bechtel corporation for the first part of his career, working on some of the largest and most unique construction projects out there. He has taken the best parts of these experiences forward with him to help create and maintain the best working environment possible at R.W. Warner.

5 Questions With Matt Cimino, Ph.D., Senior Manager at Maryland Department of Commerce

Published on : Published by : BioBuzz Media

Matt has over 30 years of experience in life sciences, business development, and entrepreneurship. He has founded and directed numerous companies, including ones that manufacture, wholesale, warehouse, and sell products on an industrial scale, as well as companies that perform environmental and analytical testing.

In Conversation with Anne Le, M.D, H.D.R., Founder and CEO of Gigantest

Published on : Published by : Sarah Ellinwood

Serving as a professor at Johns Hopkins for over a decade, Dr. Le recently decided to step out of her comfort zone and start her own company in Baltimore’s Inner Harbor, Gigantest, which provides next-level metabolomics services for scientists and physicians at leading institutions around the world.

American Gene Technologies® Professional Spotlight: Sabrina Campbell, Lab Manager

Published on : Published by : BioBuzz Media

Curing HIV is an expensive endeavor, and under Sabrina Campbell’s watchful eye, an innovative service is funding the gene therapy trial that may lead to the end of the HIV epidemic.   At the beginning of the COVID-19 pandemic, there was a shortage of PCR testing, which prompted American Gene Technologies® to open its own laboratory to bridge supply and demand. Every dollar of profit from the COVID-19 PCR tests performed in the clinical laboratory pays for the HIV Cure Program’s Phase 1 human trial. With such a critical responsibility, the clinical laboratory must operate uninterrupted, which is why we’re thrilled to highlight Sabrina Campbell, the lab manager who’s aiding a potential HIV cure with COVID-19 testing revenue.

Novavax Names John C. Jacobs as New President & Chief Executive Officer

Published on : Published by : BioBuzz Media

Novavax Names John C. Jacobs as New President & Chief Executive Officer
Jan 9, 2023
Current President & CEO Stanley C. Erck will retire effective January 23 with plans to support the leadership transition in an advisory capacity
Novavax is well-positioned to execute on its strategy, with global authorizations for its COVID-19 vaccine and continued clinical pipeline development
GAITHERSBURG, Md., Jan. 9, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that John C. Jacobs will succeed Stanley C. Erck as President and Chief Executive Officer and a member of the Board of Directors. The transition will be effective as of January 23, 2023. Mr. Erck will serve as an advisor to the Company for the next fifteen months to enable a smooth transition.
“As we prepare for Stan’s retirement, the Board reflects on the incredible legacy he leaves behind,” said James F. Young, PhD, Chairman of the Board of Directors. “Stan led Novavax from a clinical development organization to a global commercial vaccines company during a worldwide pandemic. This foundation puts Novavax in a strong position to execute on its long-term strategy, and we look…

Conexus Solutions, Inc. Announces Addition of Fred Halperin as Vice President, Commercial

Published on : Published by : BioBuzz Media

Halperin brings over 35 years of pharmaceutical industry experience to the newly created role. Prior to joining Conexus, he held several senior practice leadership roles at Accenture, Tata Consulting Services, etc., as well as in the Technology function at companies such as Johnson & Johnson, Merck, and Otsuka Pharmaceuticals. Most recently, he established and led the internal IT function for a bio-pharmaceutical start-up where he was responsible for implementing a new technology infrastructure and application portfolio to support the Commercial, R&D, and Corporate Support functions within the company.

5 Questions With Josh Green, Director of ICAP

Published on : Published by : BioBuzz Media

Josh Green is a mentor and entrepreneur whose career has primarily focused on business and organizational development. He is currently the Director of the Innovation Commercialization Assistance Program (ICAP) – a program of George Mason University and the Virginia SBDC. ICAP works with early-stage technology and innovation-driven companies to validate their market and continues to support them as they seek investment and scale their ventures. For 15 years, he has advised private companies and nonprofit organizations across the United States in a wide array of industries.

In Conversation: Barry Wells, MD, Director of Business Development, American Gene TechnologiesⓇ

Barry Wells
Published on : Published by : Steven Surdez

Rockville, Maryland’s American Gene Technologies (AGT™) HIV cure program has been making remarkable progress in its mission to bring a single-dose cure to people living with HIV. That mission is steadily advancing through a successful Phase 1 human clinical trial. The company hopes to begin its Phase 2 study during 2023; this could yield very compelling data towards a functional cure, occurring perhaps as early as the first half of 2024.

Sartorius Names Maurice Phelan as New President for North America

Published on : Published by : BioBuzz Media

Sartorius, a leading international partner of life science research and the biopharmaceutical industry, announces Maurice Phelan has assumed the role of President of Sartorius North America. He succeeds Mary Lavin, who has retired after nearly 35 years. Sartorius North America, headquartered in Bohemia, New York, currently employs more than 3,000 employees across 17 sites in the United States and Canada.